Bullboard - Stock Discussion Forum Bausch Health Companies Inc T.BHC

Alternate Symbol(s): BHC

Healthcare

Bausch Health Companies Inc. is a global diversified pharmaceutical company. The Company develops, manufactures and markets, primarily in the therapeutic areas of gastroenterology (GI), hepatology, neurology and dermatology, and others, through Bausch + Lomb Corporation. Its Salix segment consists of sales in the United States of GI products. Its International segment consists of sales, with... see more

Add To Watchlist

TSX:BHC - Post Discussion

Bausch Health Companies Inc > Bausch Health’s Bausch + Lomb to Acquire Novartis’ XIIDRA(R)

View:

Post by Betteryear2 on Jun 30, 2023 8:51am

Bausch Health’s Bausch + Lomb to Acquire Novartis’ XIIDRA(R)

LAVAL, QC / ACCESSWIRE / June 30, 2023 / Bausch + Lomb Corporation (NYSE/TSX:BLCO), a subsidiary of Bausch Health Companies Inc. (NYSE/TSX:BHC), announced that it has entered into a definitive agreement with Novartis to acquire XIIDRA® (lifitegrast ophthalmic solution) 5%, a non-steroid eye drop specifically approved to treat the signs and symptoms of dry eye disease (DED) focusing on inflammation associated with dry eye.

Bausch Health’s Bausch + Lomb to Acquire Novartis’ XIIDRA(R) (accesswire.com)

318